Expression analysis further revealed that mRNA levels of IL1B, a pro-inflammatory cytokine that is typical for an M1 polarization of monocytes, were reduced by MP treatment in healthy subjects and MS patients both in vitro and in vivo (Figure 4B). The gene discussed is IL1B; the disease is myeloid sarcoma.